Abacus Diagnostica Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 30
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $2.43M
Latest Deal Amount
  • Investors
  • 2

Abacus Diagnostica General Information

Description

Developer of rapid molecular diagnostic test system designed to make disease testing in healthcare easy, fast and cost-effective. The company's test system consists of single-use disposable test chips, a measuring device and software to interpret the test results, enabling healthcare providers with reliable molecular diagnostics that can also be used in resource and capability-limited settings.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Primary Office
  • ElectroCity
  • Tykistökatu 4 D, 2nd floor
  • 20520 Turku
  • Finland
+358 020 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abacus Diagnostica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 15-Jul-2020 $2.43M 00.000 00.000 Completed Generating Revenue/Not Profitable
2. Angel (individual) 16-Jun-2014 00000 00.000 00.000 Completed Generating Revenue
1. Later Stage VC (Series A) 16-May-2013 $5.48M $5.48M 000.00 Completed Generating Revenue
To view Abacus Diagnostica’s complete valuation and funding history, request access »

Abacus Diagnostica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 000.00 000.00 00 000.00 00.000
Ordinary 00,000 0000.00 0000.00 00 0000.00 00.000
Ordinary 2,500 $112.62 $112.62 1x $112.62 4.54%
Series A 3,000 $1576.66 $1576.66 1x $1576.66 5.45%
To view Abacus Diagnostica’s complete cap table history, request access »

Abacus Diagnostica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of rapid molecular diagnostic test system designed to make disease testing in healthcare easy, fast and cost-e
Diagnostic Equipment
Turku, Finland
30 As of 2021
00.000
0.000 0000-00-00
0000000000 00.000

0000 000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repre
0000000000 000000000
San Diego, CA
000 As of 0000
0000
0000 0000-00-00
000000&0 0000

0000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commo
0000000000 000000000
Québec, Canada
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abacus Diagnostica Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mesa Biotech Formerly VC-backed San Diego, CA 000 0000 000000&0 0000
0000000 Corporate Backed or Acquired Québec, Canada 000 000000&0
0000 00000 0000000 Corporation Rockville, MD 0000000000
00 00000000 000000 Corporate Backed or Acquired Bhopal, India 00000000000
0000000 Formerly VC-backed Sunnyvale, CA 0000 000.00 000000&0 000.00
To view Abacus Diagnostica’s complete competitors history, request access »

Abacus Diagnostica Patents

Abacus Diagnostica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2430187-A2 Method for detecting nucleic acids Withdrawn 12-May-2009 0000000000 0
US-20120040349-A1 Method for detecting nucleic acids Abandoned 12-May-2009 0000000000 0
US-20140017689-A1 Method for detecting nucleic acids Abandoned 12-May-2009 0000000000 0
US-8247171-B2 Method for detection of presence of target polynucleotide in samples Active 09-Mar-2007 0000000000 0
US-20100081139-A1 Method for detection of presence of target polynucleotide in samples Granted 01-Feb-2007 C12Q1/6818 0
To view Abacus Diagnostica’s complete patent history, request access »

Abacus Diagnostica Executive Team (4)

Name Title Board Seat Contact Info
Erno Sundberg Chief Executive Officer
You’re viewing 1 of 4 executive team members. Get the full list »

Abacus Diagnostica Board Members (4)

Name Representing Role Since
Ilkka Kouvonen Ph.D Self Board Member 000 0000
Leena Kokko Abacus Diagnostica Board Member 000 0000
Tero Soukka Abacus Diagnostica Board Member 000 0000
Timo Lövgren Abacus Diagnostica Board Member 000 0000
To view Abacus Diagnostica’s complete board members history, request access »

Abacus Diagnostica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abacus Diagnostica Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Finnvera Venture Capital Minority 000 0000 000000 0
Innovestor Venture Capital Minority 000 0000 000000 0
To view Abacus Diagnostica’s complete investors history, request access »